开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2022-09-05 水木清华观自在

刚投稿就显示under review?

85 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2022-06-08 Wang Yue

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：临床实践研究;神经康复;神经损伤的修复
经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。

112 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-12-27 MS68862005

引言和讨论之间有什么区别？

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

讨论一般分几段？

105 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-04-27 ms4000000668935484

请问审稿大概多久

126 0

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-10-29 laohahahy

明年会不会再跌呀，万一跌破怎么办？

262 0

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

301 0

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

224 0

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2011-06-29 med—doctor

明年会不会再跌呀，万一跌破怎么办？

455 0

[GetPortalCommentsPageByObjectIdResponse(id=1243401, encodeId=5bfa1243401d6, content=刚投稿就显示under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76882037324, createdName=水木清华观自在, createdTime=Mon Sep 05 23:41:44 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225291, encodeId=eb921225291d1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床实践研究;神经康复;神经损伤的修复 经验分享：期刊的格式要求相对简单容易，投稿的流程也不算繁琐。第一作者可自己投稿，不必通讯作者投稿和其他作者确认，这一点相比其他期刊，省去了一些麻烦。提交后一周就收到了编辑的回信，指出了一些手稿中的问题，修改后再提交，之后两周收到了明确的回复。在期刊回邮中，官方接受率是18%。而这个期刊的年发文量不到90篇，所以拒稿率算是挺高的。偏好于基于证据的基础和临床实践和研究，神经康复和损伤的修复。如果文章是和康复内容不太相关的可能是大概率被拒的。祝各位投稿顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epia2VEsF8RArhfrcYwibuxV7CeM6bNVYSBQOcNDUjmhsnUG669Eia8aK1L79D7Sdgxia1V2t4f0LzBbg/132, createdBy=60252347744, createdName=Wang Yue, createdTime=Wed Jun 08 22:21:29 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095541, encodeId=3f2910955410a, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095542, encodeId=cbed1095542b3, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961021, encodeId=2715961021a7, content=请问审稿大概多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90df5418248, createdName=ms4000000668935484, createdTime=Tue Apr 27 19:24:50 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548698, encodeId=f6205486980e, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160430/IMG5724C7534D0624995.jpg, createdBy=d1fc1710621, createdName=laohahahy, createdTime=Sun Oct 29 12:47:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544060, encodeId=569b544060f3, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544116, encodeId=242854411665, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481592, encodeId=850f481592f8, content=明年会不会再跌呀，万一跌破怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med—doctor, createdTime=Wed Jun 29 16:21:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=480651, encodeId=6ffd48065139, content=明年会不会降到3分呀，如果降3分以下就不值了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=499, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio_mini, createdTime=Wed Jun 29 15:48:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2011-06-29 bio_mini

明年会不会降到3分呀，如果降3分以下就不值了

499 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务